Sunday, January 18, 2026

AUTHOR NAME

Adam Marketaccess

11931 POSTS
0 COMMENTS

European Medicines Agency Evaluates Fenticonazole Safety Protocols

In a recent development that holds significance for pharmaceutical vigilance across Europe, the European Medicines Agency (EMA) has undertaken a comprehensive review of the...

Terrosa Gains EU Approval for Osteoporosis Treatment in High-Risk Patients

In a significant development for osteoporosis treatment options, Terrosa has received endorsement for use across the European Union. The approval marks an important milestone...

Rising Demand for High Technology: A Deep Dive into Industry Trends

As we propel into an era dominated by technology, companies are increasingly seeking innovative solutions to meet the growing consumer demand. This rising tide...

Abevmy Targets Cancer with Precision in the EU

In a leap forward for oncology treatments, Abevmy, a novel cancer medication, gains significant traction across Europe. With its authorization by the European Union,...

Nanox Advances Medical Imaging Presence in Western Balkans Through Adriamed Collaboration

Nanox Imaging Ltd. has taken a significant step in its European expansion efforts by entering into a strategic partnership with Adriamed, a prominent medical...

Pharmac Eases Access to Rare Disorder Treatments with Nitisinone Funding

In a transformative decision aimed at improving healthcare access for individuals with rare disorders, Pharmac announced it would fund the treatment nitisinone for patients...

Frailty Impact Surfaces in Veterans’ Long-term Care

In the evolving landscape of geriatric healthcare, assessing frailty remains crucial to enhancing the quality of life for aging populations. Veterans often face unique...

SmartCella and Catalent Drive New Stem Cell Therapies Forward with Strategic Partnership

In a monumental step for regenerative medicine, SmartCella Holding AB and Catalent, Inc. have sealed a nonexclusive license agreement enabling the use of Catalent’s...

BD Bolsters U.S. Biologics Supply Chain with Major Nebraska Expansion

Becton, Dickinson and Company (BD), a renowned global medical technology leader, takes a bold step to support the U.S. pharmaceutical supply chain with a...

ALK Prepares for Dynamic Presentation at Prestigious J.P. Morgan Healthcare Conference

Anticipation builds as ALK, a leading pharmaceutical entity in allergy immunotherapy, gears up to share its latest advancements at the upcoming J.P. Morgan Healthcare...

EU Approves Generic Antifungal Voriconazole Hikma for Fungal Infections

In a critical move to address escalating concerns over fungal infections, the European Union has granted marketing authorization to Voriconazole Hikma, a generic antifungal...

ANI Pharmaceuticals Embarks on Strategic Collaborations at Major Healthcare Conference

In the heart of the bustling pharmaceutical sector, ANI Pharmaceuticals, Inc. is gearing up to make a significant impact at the prestigious J.P. Morgan...

BD Introduces Phasixâ„¢ Mesh Hernia Prevention in Greece with Significant Milestone

BD (Becton, Dickinson and Company), a powerhouse in global medical technology, made headlines by successfully conducting the first Phasix™ Mesh laparotomy reinforcement in Greece,...

France Must Boost Hospital-Based Health Technology Assessment

The complexities of integrating medical technologies into hospital systems underscore the importance of Health Technology Assessment (HTA) in France. While HTA is pivotal for...

Analyzing Cost-Effectiveness of Anemia Management in U.S. Hemodialysis Centers

In the realm of healthcare innovation, advances in technology often promise improved outcomes and savings. Anemia, a common affliction among patients with chronic kidney...

Latest news